IRIS
BRIGANTI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.288
EU - Europa 35.763
AS - Asia 35.418
SA - Sud America 10.602
Continente sconosciuto - Info sul continente non disponibili 1.332
AF - Africa 908
OC - Oceania 105
AN - Antartide 2
Totale 120.418
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.002
RU - Federazione Russa 18.716
SG - Singapore 12.971
CN - Cina 9.762
BR - Brasile 8.586
IT - Italia 6.970
HK - Hong Kong 4.783
SE - Svezia 3.694
VN - Vietnam 3.548
FR - Francia 1.825
BD - Bangladesh 1.103
DE - Germania 1.092
CA - Canada 1.053
AR - Argentina 783
IN - India 705
GB - Regno Unito 704
FI - Finlandia 541
ID - Indonesia 496
MX - Messico 397
NL - Olanda 361
EC - Ecuador 345
RO - Romania 324
JP - Giappone 281
IQ - Iraq 280
ES - Italia 272
CO - Colombia 271
ZA - Sudafrica 264
IE - Irlanda 254
TR - Turchia 242
PL - Polonia 194
AT - Austria 181
PK - Pakistan 152
PY - Paraguay 149
CR - Costa Rica 148
UA - Ucraina 141
JM - Giamaica 139
CL - Cile 135
VE - Venezuela 134
MY - Malesia 125
MA - Marocco 114
SA - Arabia Saudita 97
UZ - Uzbekistan 95
EG - Egitto 94
PE - Perù 92
NP - Nepal 85
PH - Filippine 83
AU - Australia 81
HN - Honduras 80
KE - Kenya 77
AE - Emirati Arabi Uniti 75
TN - Tunisia 75
TT - Trinidad e Tobago 69
GT - Guatemala 66
SV - El Salvador 64
IR - Iran 63
UY - Uruguay 61
LT - Lituania 60
NI - Nicaragua 59
DZ - Algeria 56
JO - Giordania 55
NG - Nigeria 54
DO - Repubblica Dominicana 48
IL - Israele 46
KZ - Kazakistan 40
AZ - Azerbaigian 38
BE - Belgio 38
AL - Albania 37
CH - Svizzera 37
PR - Porto Rico 36
BO - Bolivia 33
PT - Portogallo 31
TH - Thailandia 31
BG - Bulgaria 30
GR - Grecia 30
KR - Corea 30
LB - Libano 29
MD - Moldavia 26
TW - Taiwan 26
CZ - Repubblica Ceca 25
NO - Norvegia 25
PA - Panama 25
RS - Serbia 25
BB - Barbados 22
OM - Oman 22
CW - ???statistics.table.value.countryCode.CW??? 21
SN - Senegal 21
BA - Bosnia-Erzegovina 20
BH - Bahrain 19
SC - Seychelles 19
GP - Guadalupe 18
HU - Ungheria 18
EE - Estonia 17
KG - Kirghizistan 17
TZ - Tanzania 17
DK - Danimarca 16
KH - Cambogia 16
PS - Palestinian Territory 16
NZ - Nuova Zelanda 15
AO - Angola 13
BY - Bielorussia 13
Totale 118.784
Salva come PNG Salva come JPEG
Città #
Singapore 5.167
Ashburn 4.859
Hong Kong 4.721
Dallas 4.245
Moscow 4.243
San Jose 3.690
Council Bluffs 2.108
Shanghai 1.848
Milan 1.826
Hefei 1.801
Princeton 1.715
Lawrence 1.710
Lauterbourg 1.525
Ho Chi Minh City 1.326
New York 937
Beijing 898
Santa Clara 807
Hanoi 748
São Paulo 679
Los Angeles 623
Rome 422
Helsinki 412
North Bergen 402
Phoenix 356
Miano 339
Rio de Janeiro 265
Dublin 237
Montreal 223
Boardman 220
Atlanta 206
Orem 205
Brooklyn 204
Nuremberg 193
Chicago 189
Munich 189
Belo Horizonte 185
Naples 175
Da Nang 171
Brasília 164
Denver 164
Chennai 156
Turin 155
Warsaw 151
Toronto 147
Tokyo 146
Haiphong 136
Guangzhou 134
Bologna 130
Porto Alegre 127
Johannesburg 125
Houston 124
Curitiba 120
Mexico City 119
Washington 115
Frankfurt am Main 112
London 112
Boston 110
Quito 110
San José 109
Seattle 109
Guayaquil 108
Buffalo 105
Florence 104
Salvador 98
Campinas 96
Miami 96
Baghdad 94
Turku 93
Stockholm 91
Tianjin 91
Biên Hòa 87
San Francisco 85
Tashkent 85
Thái Bình 85
Valencia 84
Philadelphia 83
Manchester 82
Guarulhos 81
Mumbai 81
Vienna 80
Amsterdam 79
Dhaka 78
Hải Dương 78
Poplar 78
Ribeirão Preto 78
Pune 76
Kingston 74
Kuala Lumpur 72
Manaus 72
Palermo 70
Bogotá 69
Hangzhou 69
Buenos Aires 66
Jakarta 66
The Dalles 64
Columbus 63
Fortaleza 63
Lima 62
Brescia 61
Las Vegas 61
Totale 56.152
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 2.151
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.458
Benign Prostatic Hyperplasia and Its Aetiologies 521
Women's sexual dysfunction: a pathophysiological review 327
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 288
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 281
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 274
Bladder cancer incidence rates and trends in young adults aged 20-39 years 271
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis 267
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 253
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 247
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 246
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 213
Pelvic lymph node dissection in prostate cancer 208
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 203
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 201
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 200
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 193
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 188
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 188
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 182
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 180
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 178
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 178
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 177
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 177
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 173
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 173
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 171
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 164
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 163
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 163
A mechanistic insight into the anti-metastatic role of the prostate specific antigen 162
Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? 161
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 156
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 156
Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up 155
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 153
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 153
Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates 152
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 152
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 151
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 151
120-MONTH MEDIAN FOLLOW-UP OF INTRACAVERNOUS INJECTION THERAPY FOR ERECTILE DYSFUNCTION 150
How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder 150
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 149
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer – a systematic review and meta-analysis 148
Prediction of Functional Outcomes After Nerve-Sparing Radical Prostatectomy: Results of Conditional Survival Analyses 148
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma 148
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 147
Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve 146
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 146
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer 146
How to Select the Optimal Candidates for Renal Mass Biopsy 146
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment 146
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 145
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 144
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study 144
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 144
A MINIMUM OF 14 CORES SHOULD BE TAKEN AT BIOPSY BEFORE PLANNING ACTIVE SURVEILLANCE FOR PATIENTS WITH LOW-RISK PROSTATE CANCER 143
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 143
A propensity score approach for treatment evaluation based on Bayesian Networks 143
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 143
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 142
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy 142
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis 141
Effectiveness of a Combination of Cranberries, Lactobacillus rhamnosus, and Vitamin C for the Management of Recurrent Urinary Tract Infections in Women: Results of a Pilot Study 141
A CRITICAL APPRAISAL OF THE ABILITY OF BODY MASS INDEX (BMI) TO PREDICT HIGH-GRADE PROSTATE CANCER (PCA) 141
A critical analysis of Permixon (TM) in the treatment of lower urinary tract symptoms due to benign prostatic enlargement 141
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 140
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 139
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 139
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 138
ROBOT-ASSISTED RADICAL PROSTATECTOMY IS ASSOCIATED WITH FASTER AND GREATER RECOVERY FROM ORGASM ASSOCIATED INCONTINENCE 138
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 138
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus 137
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 137
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 136
Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer 136
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 136
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 135
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 134
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 134
[11C]CHOLINE PET/CT for Early Detection of Tumor in Prostate Cancer Patients with PSA Level Lower Than 1.5 NG/ML 134
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 134
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis 133
Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis 132
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 132
30-DAY MORTALITY AFTER RADICAL PROSTATECTOMY IN OVER 9000 PATIENTS: VALIDATION OF A PREDICTIVE NOMOGRAM 132
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 131
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors 130
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 129
A risk calculator predicting recurrence in lymph node metastatic penile cancer 129
Supplementary Data from Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models 128
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 128
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 128
A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals 128
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 128
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 128
Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models 128
Totale 19.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 788.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 788.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022989 0 0 0 464 59 58 95 67 33 60 43 110
2022/20238.177 3.959 1.455 485 70 52 804 299 457 256 84 137 119
2023/20243.865 149 210 328 296 295 574 217 373 84 317 466 556
2024/202521.927 3.053 565 362 531 501 1.789 2.790 1.624 4.142 3.496 1.417 1.657
2025/202665.753 4.408 5.874 6.280 10.073 4.204 1.508 5.649 4.231 16.295 3.266 1.882 2.083
2026/202718.864 2.538 4.122 3.826 8.378 0 0 0 0 0 0 0 0
Totale 120.418